Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS005 in moderate to severe plaque psoriasis
NCT05344248Phase 2Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Jan 2021
- Primary completion
- Oct 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of roconkibart in plaque psoriasis, sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Jan 2021; status: completed.
02
Drugs
roconkibart
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05344248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05344248.